Infant sex, obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants

Arsenio Spinillo1, Laura Montanari, Barbara Gardella

  • 1University of Pavia, Department of Obstetrics and Gynecology, IRCCS Fondazione Policlinico San Matteo, P le Golgi, 25, Pavia 27100, Italy. spinillo@smatteo.pv.it

Insights

Male preterm infants face higher neurodevelopmental impairment risks, especially with certain obstetric complications. These risks are influenced by factors like preeclampsia and delivery type, highlighting the impact of maternal health on infant outcomes.

Area of Science:

  • Neonatal neurology
  • Perinatal medicine
  • Developmental pediatrics

Background:

  • Preterm birth is a major risk factor for neurodevelopmental impairment (NDI).
  • Fetal sex is increasingly recognized as a potential modulator of infant health outcomes.
  • The interplay between fetal sex and obstetric factors in NDI risk is not fully understood.

Purpose of the Study:

  • To investigate the interaction between fetal sex and obstetric variables.
  • To determine their combined effect on the risk of neurodevelopmental impairment in preterm infants.

Main Methods:

  • A cohort study included 754 surviving infants born between 24 and 33 weeks of gestational age.
  • Neurological examinations and cognitive assessments (Bayley Scales of Infant Development) were conducted at 2 years corrected age.
  • Logistic regression analysis was used to evaluate the association between male sex, obstetric variables, and NDI.

Main Results:

  • Male infants had a significantly increased risk of neurodevelopmental impairment (OR 1.8) compared to females.
  • The excess risk for males was amplified in pregnancies complicated by preeclampsia.
  • Male sex interaction with small-for-gestational-age status and iatrogenic preterm birth also increased NDI risk.

Conclusions:

  • Fetal sex is a significant factor influencing neurodevelopmental impairment risk in preterm infants.
  • Obstetric risk factors, including preeclampsia and delivery type, modulate this sex-based risk.
  • These findings underscore the importance of considering both fetal sex and maternal/pregnancy factors in managing preterm infants.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...